FUL logo

FUL

H. B. Fuller Company

$60.98
+$0.88(+1.46%)
67
Overall
100
Value
50
Tech
52
Quality
Market Cap
$3.14B
Volume
340.83K
52W Range
$47.56 - $67.05
Target Price
$71.71

Company Overview

Mkt Cap$3.14BPrice$60.98
Volume340.83KChange+1.46%
P/E Ratio24.1Open$60.00
Revenue$3.6BPrev Close$60.10
Net Income$130.3M52W Range$47.56 - $67.05
Div Yield0.94%Target$71.71
Overall67Value100
Quality52Technical50

No chart data available

About H. B. Fuller Company

H.B. Fuller Company, together with its subsidiaries, formulates, manufactures, and markets adhesives, sealants, coatings, polymers, tapes, encapsulants, additives, and other specialty chemical products. It operates through three segments: Hygiene, Health and Consumable Adhesives; Engineering Adhesives; and Construction Adhesives. The Hygiene, Health and Consumable Adhesives segment produces and supplies specialty industrial adhesives, such as thermoplastic, thermoset, reactive, water-based, and solvent-based products for applications in various markets, including packaging, converting, nonwoven and hygiene, and health and beauty. The Engineering Adhesives segment produces and supplies high performance industrial adhesives comprising reactive, light cure, two-part liquids, polyurethane, silicone, film, and fast cure products to the durable assembly, performance wood and textile, transportation, electronics, clean energy, aerospace and defense, appliance, heavy machinery, and insulating glass markets. The Construction Adhesives segment provides products used for tile setting, commercial roofing, heating, ventilation, and air conditioning and insulation applications, as well as caulks and sealants for the consumer market and professional trade. The company sells its products directly to customers, as well as through distributors and retailers in North America, Latin America, Europe, India, the Middle East, Africa, and the Asia Pacific. H.B. Fuller Company was founded in 1887 and is headquartered in Saint Paul, Minnesota.

Sector: Basic Materials
Industry: Specialty Chemicals

Latest News

Truist Financial Sticks to Their Buy Rating for Fulcrum Therapeutics (FULC)

In a report released today, Gregory Renza from Truist Financial reiterated a Buy rating on Fulcrum Therapeutics, with a price target of $18.00. Acc...

TipRanks Auto-Generated Intelligence Newsdeska day ago

Fulcrum Lithium Launches Major Phase 3 Drilling at Nevada Alkali Flats Project

TipRanks Australian Auto-Generated Newsdesk6 days ago

Fulcrum Lithium Expands Nevada Footprint as Testwork and Permits Advance Key Projects

TipRanks Australian Auto-Generated Newsdesk8 days ago

H.B. Fuller’s Rising Regulatory Reporting Risks: Global Climate and Disclosure Rules Threaten Costs, Operations, and Reputation

TipRanks Auto-Generated Newsdesk9 days ago

Fulcrum Lithium Advances Alkali Flats Drilling as Lithium Prices Rebound

TipRanks Australian Auto-Generated Newsdesk15 days ago
ABCD
1SymbolPriceChangeVol
2FUL$60.98+1.5%340.83K
3
4
5
6

Get H. B. Fuller Company Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.